日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ASOs are an effective treatment for disease-associated oligodendrocyte signatures in premanifest and symptomatic SCA3 mice.

ASO 可有效治疗 SCA3 前驱期和症状期小鼠的疾病相关少突胶质细胞特征

Schuster Kristen H, Zalon Annie J, DiFranco Danielle M, Putka Alexandra F, Stec Nicholas R, Jarrah Sabrina I, Naeem Arsal, Haque Zaid, Zhang Hanrui, Guan Yuanfang, McLoughlin Hayley S